Digital PCR (dPCR) and qPCR Market by Technology (Quantitative, Digital), Product (Instrument, Reagent, Software), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Center, Academia, Pharma-Biotech Co) - Global Forecasts to 2021
The global qPCR and dPCR market is expected to reach USD 4.94 billion by 2021 from USD 3.28 billion in 2016, growing at a CAGR of 8.5% during the forecast period. Market growth can be attributed to the rising incidences of infectious diseases and genetic disorders (coupled with growing geriatric population that is at greater risk of target diseases as compared to adults); technological advancements; increasing public-private investments, funds, and grants; successful completion of the Human Genome Project, and rise in the number of hospitals and diagnostic centers.
In this report, the global qPCR and dPCR market is segmented on the basis of technology, products and services, applications, and end users. On the basis of technology, the market is further segmented into qPCR and dPCR. On the basis of products and services, the market is further segmented into instruments, reagents, and consumables; software; and services. On the basis of applications, the market is further segmented into clinical applications, research applications, and forensic applications. On the basis of end users, the market is further segmented into research labs and academic institutes, pharma and biotech companies, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories.
Geographically, North America is expected to account for the largest share of the global qPCR and dPCR market in 2016, followed by Europe. Factors such as increase in public and private funding and increasing financial support (in the form of research grants and funding projects) from prominent funding agencies and federal institutions for the R&D of innovative qPCR and dPCR products are driving the qPCR and dPCR market in the North America region. However, Asia-Pacific (comprising China, India, Japan, and the Rest of Asia-Pacific) is projected to be the fastest-growing region in the qPCR and dPCR market during the forecast period, owing to factors such as increasing focus of global life sciences companies on this region, burgeoning efforts to increase awareness related to gene-based disease diagnosis and treatment, growing public and private support to develop novel qPCR and dPCR technologies, growth in the Indian genomics market, and strengthening cancer research in Japan, among others.
In 2015, the global qPCR and dPCR devices market was dominated by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (The Netherlands), and Agilent Technologies, Inc. (U.S.). These top five market players jointly accounted for ~87.0% of the global qPCR and dPCR market in 2015.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis, such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the qPCR and dPCR market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
In this report, the global qPCR and dPCR market is segmented on the basis of technology, products and services, applications, and end users. On the basis of technology, the market is further segmented into qPCR and dPCR. On the basis of products and services, the market is further segmented into instruments, reagents, and consumables; software; and services. On the basis of applications, the market is further segmented into clinical applications, research applications, and forensic applications. On the basis of end users, the market is further segmented into research labs and academic institutes, pharma and biotech companies, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories.
Geographically, North America is expected to account for the largest share of the global qPCR and dPCR market in 2016, followed by Europe. Factors such as increase in public and private funding and increasing financial support (in the form of research grants and funding projects) from prominent funding agencies and federal institutions for the R&D of innovative qPCR and dPCR products are driving the qPCR and dPCR market in the North America region. However, Asia-Pacific (comprising China, India, Japan, and the Rest of Asia-Pacific) is projected to be the fastest-growing region in the qPCR and dPCR market during the forecast period, owing to factors such as increasing focus of global life sciences companies on this region, burgeoning efforts to increase awareness related to gene-based disease diagnosis and treatment, growing public and private support to develop novel qPCR and dPCR technologies, growth in the Indian genomics market, and strengthening cancer research in Japan, among others.
In 2015, the global qPCR and dPCR devices market was dominated by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (The Netherlands), and Agilent Technologies, Inc. (U.S.). These top five market players jointly accounted for ~87.0% of the global qPCR and dPCR market in 2015.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis, such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the qPCR and dPCR market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the qPCR and dPCR products offered by the top 10 players in the global market. The report analyzes the qPCR and dPCR products market by products and services, applications, and end users across key geographic regions
- Product Development/Innovation: Detailed insights on upcoming qPCR and dPCR products, research and development activities, and new product launches in the market
- Market Development: Comprehensive information on the lucrative emerging markets. The report analyzes the markets for various qPCR and dPCR products across key geographic regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global qPCR and dPCR market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global qPCR and dPCR market
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
2.2.2.1 Healthcare expenditure patterns
2.2.2.2 Rapid growth of aging population
2.2.2.3 Incidence and prevalence of cancer
2.2.2.4 Birth rate/pregnancies
2.2.2.5 Burden of infectious diseases
2.2.2.6 Number of clinical, forensics, and research laboratories
2.2.3 SUPPLY-SIDE ANALYSIS
2.2.3.1 Number of new product launches: qPCR and dPCR Vs. competitive technologies
2.2.3.2 Parent market analysis: Polymerase chain reaction (PCR) market
2.3 MARKET SIZE ESTIMATION
2.3.1 TOP-DOWN APPROACH
2.3.2 BOTTOM-UP APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.5.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 HISTORY, EVOLUTION, AND CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL qPCR AND dPCR MARKET (2016-2021)
4.2 GLOBAL qPCR AND dPCR TECHNOLOGY MARKET, BY REGION (2016–2021)
4.3 GLOBAL qPCR AND dPCR MARKET SHARE, BY PRODUCT AND SERVICE (2016)
4.4 GLOBAL qPCR AND dPCR MARKET, BY APPLICATION (2016)
4.5 GLOBAL qPCR AND dPCR MARKET SHARE, BY APPLICATION (2016)
4.6 GLOBAL qPCR AND dPCR MARKET SHARE, BY END USER (2016–2021)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 TECHNOLOGICAL EVOLUTION IN qPCR/dPCR
5.3 MARKET SEGMENTATION
5.4 MARKET DYNAMICS
5.4.1 DRIVERS
5.4.1.1 Rising incidences of infectious diseases and genetic disorders
5.4.1.2 Technological advancements
5.4.1.3 Increasing public–private investments, funds, and grants
5.4.1.4 Successful completion of the Human Genome Project
5.4.2 RESTRAINTS
5.4.2.1 High device costs associated with dPCR
5.4.2.2 Technical limitations of qPCR and dPCR techniques
5.4.3 OPPORTUNITIES
5.4.3.1 Growing market penetration in emerging countries
5.4.3.2 Shift from plant-derived to genome-based drug discovery
5.4.4 CHALLENGES
5.4.4.1 Adoption and implementation of MIQE guidelines for publishing qPCR and dPCR-based research
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 INDUSTRY TRENDS
6.3.1 DEVELOPMENT OF LAB-ON-CHIP PCR DEVICES
6.3.2 ONGOING TECHNOLOGICAL INTEGRATION WITH PCR PROCESS
6.4 PORTER’S FIVE FORCES ANALYSIS
6.4.1 REAL-TIME PCR (qPCR) MARKET: PORTER’S FIVE FORCES ANALYSIS
6.4.1.1 Threat from new entrants
6.4.1.2 Threat from substitutes
6.4.1.3 Bargaining power of suppliers
6.4.1.4 Bargaining power of buyers
6.4.1.5 Intensity of competitive rivalry
6.4.2 DIGITAL PCR (dPCR) MARKET: PORTER’S FIVE FORCES ANALYSIS
6.4.2.1 Threat from new entrants
6.4.2.2 Threat from substitutes
6.4.2.3 Bargaining power of suppliers
6.4.2.4 Bargaining power of buyers
6.4.2.5 Intensity of competitive rivalry
7 GLOBAL QPCR AND DPCR MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 QUANTITATIVE PCR (qPCR)
7.3 DIGITAL PCR (dPCR)
8 GLOBAL QPCR AND DPCR MARKET, BY PRODUCT AND SERVICES
8.1 INTRODUCTION
8.2 qPCR PRODUCT AND SERVICES
8.2.1 qPCR REAGENTS AND CONSUMABLES
8.2.2 qPCR INSTRUMENTS
8.2.3 qPCR SOFTWARE AND SERVICES
8.3 dPCR PRODUCT AND SERVICES
8.3.1 dPCR INSTRUMENTS
8.3.2 dPCR REAGENTS AND CONSUMABLES
8.3.3 dPCR SOFTWARE AND SERVICES
9 QPCR AND DPCR MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 qPCR APPLICATIONS
9.2.1 CLINICAL APPLICATIONS
9.2.2 RESEARCH APPLICATIONS
9.2.3 FORENSIC APPLICATIONS
9.3 dPCR APPLICATIONS
9.3.1 CLINICAL APPLICATIONS
9.3.2 RESEARCH APPLICATIONS
9.3.3 FORENSIC APPLICATIONS
10 QPCR AND DPCR MARKET, BY END USER
10.1 INTRODUCTION
10.2 QUANTITATIVE PCR (qPCR) END USERS
10.2.1 HOSPITALS AND DIAGNOSTIC CENTERS
10.2.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
10.2.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.2.4 CLINICAL RESEARCH ORGANIZATIONS
10.2.5 FORENSIC LABORATORIES
10.3 DIGITAL PCR (dPCR) END USERS
10.3.1 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
10.3.2 HOSPITALS AND DIAGNOSTIC CENTERS
10.3.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.4 CLINICAL RESEARCH ORGANIZATIONS
10.3.5 FORENSIC LABORATORIES
11 QPCR AND DPCR MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 U.S.
11.3 EUROPE
11.4 ASIA-PACIFIC
11.5 REST OF THE WORLD (ROW)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.2.1 qPCR MARKET SHARE ANALYSIS (2015)
12.2.2 dPCR MARKET SHARE ANALYSIS (2015)
12.3 COMPETITIVE SCENARIO
12.4 RECENT DEVELOPMENTS
12.4.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
12.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
12.4.3 MERGERS AND ACQUISITIONS
12.4.4 GEOGRAPHICAL EXPANSIONS
12.4.5 OTHER DEVELOPMENTS
13 COMPANY PROFILES
13.1 INTRODUCTION
13.1.1 GEOGRAPHIC BENCHMARKING
13.1.2 STRATEGIC OUTLOOK
13.1.2.1 Product development and commercialization
13.2 THERMO FISHER SCIENTIFIC, INC.
13.2.1 BUSINESS OVERVIEW
13.2.2 PRODUCTS & SERVICES
13.2.3 RECENT DEVELOPMENTS
13.2.4 MNM VIEW
13.3 BIO-RAD LABORATORIES, INC.
13.3.1 BUSINESS OVERVIEW
13.3.2 PRODUCTS & SERVICES
13.3.3 RECENT DEVELOPMENTS
13.3.4 MNM VIEW
13.4 F. HOFFMAN-LA ROCHE LTD.
13.4.1 BUSINESS OVERVIEW
13.4.2 PRODUCTS & SERVICES
13.4.3 RECENT DEVELOPMENTS
13.4.4 MNM VIEW
13.5 QIAGEN N.V.
13.5.1 BUSINESS OVERVIEW
13.5.2 PRODUCTS OFFERED
13.5.3 RECENT DEVELOPMENTS
13.5.4 MNM VIEW
13.6 AGILENT TECHNOLOGIES, INC.
13.6.1 BUSINESS OVERVIEW
13.6.2 PRODUCTS OFFERED
13.6.3 RECENT DEVELOPMENTS
13.6.4 MNM VIEW
13.7 TAKARA BIO, INC.
13.7.1 BUSINESS OVERVIEW
13.7.2 PRODUCTS OFFERED
13.7.3 RECENT DEVELOPMENTS
13.8 BIOM?RIEUX S.A.
13.8.1 BUSINESS OVERVIEW
13.8.2 PRODUCTS & SERVICES
13.8.3 RECENT DEVELOPMENTS
13.9 AFFYMETRIX, INC.
13.9.1 BUSINESS OVERVIEW
13.9.2 PRODUCTS OFFERED
13.9.3 RECENT DEVELOPMENTS
13.10 FLUIDIGM CORPORATION
13.10.1 BUSINESS OVERVIEW
13.10.2 PRODUCTS OFFERED
13.10.3 RECENT DEVELOPMENTS
13.11 RAINDANCE TECHNOLOGIES, INC.
13.11.1 BUSINESS OVERVIEW
13.11.2 PRODUCTS AND SERVICES
13.11.3 RECENT DEVELOPMENTS
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
14.5 AVAILABLE CUSTOMIZATIONS
14.6 RELATED REPORTS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
2.2.2.1 Healthcare expenditure patterns
2.2.2.2 Rapid growth of aging population
2.2.2.3 Incidence and prevalence of cancer
2.2.2.4 Birth rate/pregnancies
2.2.2.5 Burden of infectious diseases
2.2.2.6 Number of clinical, forensics, and research laboratories
2.2.3 SUPPLY-SIDE ANALYSIS
2.2.3.1 Number of new product launches: qPCR and dPCR Vs. competitive technologies
2.2.3.2 Parent market analysis: Polymerase chain reaction (PCR) market
2.3 MARKET SIZE ESTIMATION
2.3.1 TOP-DOWN APPROACH
2.3.2 BOTTOM-UP APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.5.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 HISTORY, EVOLUTION, AND CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL qPCR AND dPCR MARKET (2016-2021)
4.2 GLOBAL qPCR AND dPCR TECHNOLOGY MARKET, BY REGION (2016–2021)
4.3 GLOBAL qPCR AND dPCR MARKET SHARE, BY PRODUCT AND SERVICE (2016)
4.4 GLOBAL qPCR AND dPCR MARKET, BY APPLICATION (2016)
4.5 GLOBAL qPCR AND dPCR MARKET SHARE, BY APPLICATION (2016)
4.6 GLOBAL qPCR AND dPCR MARKET SHARE, BY END USER (2016–2021)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 TECHNOLOGICAL EVOLUTION IN qPCR/dPCR
5.3 MARKET SEGMENTATION
5.4 MARKET DYNAMICS
5.4.1 DRIVERS
5.4.1.1 Rising incidences of infectious diseases and genetic disorders
5.4.1.2 Technological advancements
5.4.1.3 Increasing public–private investments, funds, and grants
5.4.1.4 Successful completion of the Human Genome Project
5.4.2 RESTRAINTS
5.4.2.1 High device costs associated with dPCR
5.4.2.2 Technical limitations of qPCR and dPCR techniques
5.4.3 OPPORTUNITIES
5.4.3.1 Growing market penetration in emerging countries
5.4.3.2 Shift from plant-derived to genome-based drug discovery
5.4.4 CHALLENGES
5.4.4.1 Adoption and implementation of MIQE guidelines for publishing qPCR and dPCR-based research
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 INDUSTRY TRENDS
6.3.1 DEVELOPMENT OF LAB-ON-CHIP PCR DEVICES
6.3.2 ONGOING TECHNOLOGICAL INTEGRATION WITH PCR PROCESS
6.4 PORTER’S FIVE FORCES ANALYSIS
6.4.1 REAL-TIME PCR (qPCR) MARKET: PORTER’S FIVE FORCES ANALYSIS
6.4.1.1 Threat from new entrants
6.4.1.2 Threat from substitutes
6.4.1.3 Bargaining power of suppliers
6.4.1.4 Bargaining power of buyers
6.4.1.5 Intensity of competitive rivalry
6.4.2 DIGITAL PCR (dPCR) MARKET: PORTER’S FIVE FORCES ANALYSIS
6.4.2.1 Threat from new entrants
6.4.2.2 Threat from substitutes
6.4.2.3 Bargaining power of suppliers
6.4.2.4 Bargaining power of buyers
6.4.2.5 Intensity of competitive rivalry
7 GLOBAL QPCR AND DPCR MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 QUANTITATIVE PCR (qPCR)
7.3 DIGITAL PCR (dPCR)
8 GLOBAL QPCR AND DPCR MARKET, BY PRODUCT AND SERVICES
8.1 INTRODUCTION
8.2 qPCR PRODUCT AND SERVICES
8.2.1 qPCR REAGENTS AND CONSUMABLES
8.2.2 qPCR INSTRUMENTS
8.2.3 qPCR SOFTWARE AND SERVICES
8.3 dPCR PRODUCT AND SERVICES
8.3.1 dPCR INSTRUMENTS
8.3.2 dPCR REAGENTS AND CONSUMABLES
8.3.3 dPCR SOFTWARE AND SERVICES
9 QPCR AND DPCR MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 qPCR APPLICATIONS
9.2.1 CLINICAL APPLICATIONS
9.2.2 RESEARCH APPLICATIONS
9.2.3 FORENSIC APPLICATIONS
9.3 dPCR APPLICATIONS
9.3.1 CLINICAL APPLICATIONS
9.3.2 RESEARCH APPLICATIONS
9.3.3 FORENSIC APPLICATIONS
10 QPCR AND DPCR MARKET, BY END USER
10.1 INTRODUCTION
10.2 QUANTITATIVE PCR (qPCR) END USERS
10.2.1 HOSPITALS AND DIAGNOSTIC CENTERS
10.2.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
10.2.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.2.4 CLINICAL RESEARCH ORGANIZATIONS
10.2.5 FORENSIC LABORATORIES
10.3 DIGITAL PCR (dPCR) END USERS
10.3.1 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
10.3.2 HOSPITALS AND DIAGNOSTIC CENTERS
10.3.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.4 CLINICAL RESEARCH ORGANIZATIONS
10.3.5 FORENSIC LABORATORIES
11 QPCR AND DPCR MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 U.S.
11.3 EUROPE
11.4 ASIA-PACIFIC
11.5 REST OF THE WORLD (ROW)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.2.1 qPCR MARKET SHARE ANALYSIS (2015)
12.2.2 dPCR MARKET SHARE ANALYSIS (2015)
12.3 COMPETITIVE SCENARIO
12.4 RECENT DEVELOPMENTS
12.4.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
12.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
12.4.3 MERGERS AND ACQUISITIONS
12.4.4 GEOGRAPHICAL EXPANSIONS
12.4.5 OTHER DEVELOPMENTS
13 COMPANY PROFILES
13.1 INTRODUCTION
13.1.1 GEOGRAPHIC BENCHMARKING
13.1.2 STRATEGIC OUTLOOK
13.1.2.1 Product development and commercialization
13.2 THERMO FISHER SCIENTIFIC, INC.
13.2.1 BUSINESS OVERVIEW
13.2.2 PRODUCTS & SERVICES
13.2.3 RECENT DEVELOPMENTS
13.2.4 MNM VIEW
13.3 BIO-RAD LABORATORIES, INC.
13.3.1 BUSINESS OVERVIEW
13.3.2 PRODUCTS & SERVICES
13.3.3 RECENT DEVELOPMENTS
13.3.4 MNM VIEW
13.4 F. HOFFMAN-LA ROCHE LTD.
13.4.1 BUSINESS OVERVIEW
13.4.2 PRODUCTS & SERVICES
13.4.3 RECENT DEVELOPMENTS
13.4.4 MNM VIEW
13.5 QIAGEN N.V.
13.5.1 BUSINESS OVERVIEW
13.5.2 PRODUCTS OFFERED
13.5.3 RECENT DEVELOPMENTS
13.5.4 MNM VIEW
13.6 AGILENT TECHNOLOGIES, INC.
13.6.1 BUSINESS OVERVIEW
13.6.2 PRODUCTS OFFERED
13.6.3 RECENT DEVELOPMENTS
13.6.4 MNM VIEW
13.7 TAKARA BIO, INC.
13.7.1 BUSINESS OVERVIEW
13.7.2 PRODUCTS OFFERED
13.7.3 RECENT DEVELOPMENTS
13.8 BIOM?RIEUX S.A.
13.8.1 BUSINESS OVERVIEW
13.8.2 PRODUCTS & SERVICES
13.8.3 RECENT DEVELOPMENTS
13.9 AFFYMETRIX, INC.
13.9.1 BUSINESS OVERVIEW
13.9.2 PRODUCTS OFFERED
13.9.3 RECENT DEVELOPMENTS
13.10 FLUIDIGM CORPORATION
13.10.1 BUSINESS OVERVIEW
13.10.2 PRODUCTS OFFERED
13.10.3 RECENT DEVELOPMENTS
13.11 RAINDANCE TECHNOLOGIES, INC.
13.11.1 BUSINESS OVERVIEW
13.11.2 PRODUCTS AND SERVICES
13.11.3 RECENT DEVELOPMENTS
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
14.5 AVAILABLE CUSTOMIZATIONS
14.6 RELATED REPORTS
LIST OF TABLES
Table 1 GLOBAL qPCR AND dPCR MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 2 GLOBAL qPCR TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 3 GLOBAL dPCR TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 4 GLOBAL qPCR PRODUCTS AND SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 5 qPCR REAGENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 6 qPCR INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 7 qPCR SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 8 GLOBAL dPCR PRODUCT AND SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 9 dPCR INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 10 dPCR REAGENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 11 dPCR SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 12 qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 13 qPCR CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 14 qPCR RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 15 qPCR FORENSIC APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 16 dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 17 dPCR CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 18 dPCR RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 19 DPCR FORENSIC APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 20 GLOBAL qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 21 qPCR MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2014-2021 (USD MILLION)
Table 22 qPCR MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
Table 23 qPCR MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
Table 24 qPCR MARKET SIZE FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
Table 25 qPCR MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
Table 26 GLOBAL dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 27 dPCR MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
Table 28 dPCR MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2014-2021 (USD MILLION)
Table 29 dPCR MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
Table 30 dPCR MARKET SIZE FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
Table 31 dPCR MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
Table 32 qPCR AND dPCR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 33 NORTH AMERICA: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 34 NORTH AMERICA: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 35 NORTH AMERICA: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 36 NORTH AMERICA: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 37 NORTH AMERICA: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 38 NORTH AMERICA: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 39 U.S.: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 40 U.S.: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 41 U.S.: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 42 U.S.: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 43 U.S.: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 44 U.S.: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 45 EUROPE: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 46 EUROPE: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 47 EUROPE: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 48 EUROPE: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 49 EUROPE: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 50 EUROPE: DPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 51 ASIA-PACIFIC: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 52 ASIA-PACIFIC: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 53 ASIA-PACIFIC: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 54 ASIA-PACIFIC: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 55 ASIA-PACIFIC: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 56 ASIA-PACIFIC: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 57 ROW: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 58 ROW: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 59 ROW: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 60 ROW: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 61 ROW: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 62 ROW: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 63 TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012–2015
Table 64 TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2015
Table 65 TOP 5 MERGERS AND ACQUISITIONS, 2012–2015
Table 66 TOP 5 GEOGRAPHICAL EXPANSIONS, 2012–2015
Table 67 TOP OTHER DEVELOPMENTS, 2012–2015
Table 1 GLOBAL qPCR AND dPCR MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 2 GLOBAL qPCR TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 3 GLOBAL dPCR TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 4 GLOBAL qPCR PRODUCTS AND SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 5 qPCR REAGENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 6 qPCR INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 7 qPCR SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 8 GLOBAL dPCR PRODUCT AND SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 9 dPCR INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 10 dPCR REAGENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 11 dPCR SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 12 qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 13 qPCR CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 14 qPCR RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 15 qPCR FORENSIC APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 16 dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 17 dPCR CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 18 dPCR RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 19 DPCR FORENSIC APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 20 GLOBAL qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 21 qPCR MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2014-2021 (USD MILLION)
Table 22 qPCR MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
Table 23 qPCR MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
Table 24 qPCR MARKET SIZE FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
Table 25 qPCR MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
Table 26 GLOBAL dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 27 dPCR MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
Table 28 dPCR MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2014-2021 (USD MILLION)
Table 29 dPCR MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
Table 30 dPCR MARKET SIZE FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
Table 31 dPCR MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
Table 32 qPCR AND dPCR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 33 NORTH AMERICA: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 34 NORTH AMERICA: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 35 NORTH AMERICA: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 36 NORTH AMERICA: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 37 NORTH AMERICA: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 38 NORTH AMERICA: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 39 U.S.: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 40 U.S.: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 41 U.S.: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 42 U.S.: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 43 U.S.: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 44 U.S.: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 45 EUROPE: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 46 EUROPE: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 47 EUROPE: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 48 EUROPE: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 49 EUROPE: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 50 EUROPE: DPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 51 ASIA-PACIFIC: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 52 ASIA-PACIFIC: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 53 ASIA-PACIFIC: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 54 ASIA-PACIFIC: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 55 ASIA-PACIFIC: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 56 ASIA-PACIFIC: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 57 ROW: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 58 ROW: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
Table 59 ROW: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 60 ROW: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 61 ROW: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 62 ROW: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 63 TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012–2015
Table 64 TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2015
Table 65 TOP 5 MERGERS AND ACQUISITIONS, 2012–2015
Table 66 TOP 5 GEOGRAPHICAL EXPANSIONS, 2012–2015
Table 67 TOP OTHER DEVELOPMENTS, 2012–2015
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2000-2013
Figure 3 HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS: 2000-2013
Figure 4 HEALTHCARE SPENDING MATRIX: KEY MARKETS (2013)
Figure 5 INCREASE IN AGING POPULATION, BY COUNTRY (2011-2030)
Figure 6 PERCENTAGE INCREASE IN AGING POPULATION, BY REGION (1980–2010 VS. 2010–2040)
Figure 7 GLOBAL BURDEN OF CANCER, BY REGION (2005–2030)
Figure 8 NUMBER OF NEW CANCER CASES, BY COUNTRY (2012 VS. 2020)
Figure 9 INCREASING INCIDENCE OF VARIOUS CANCERS, 2008–2020
Figure 10 ANNUAL BIRTH RATE IN DEVELOPED AND DEVELOPING NATIONS (2014)
Figure 11 GLOBAL PREVALENCE OF HIV INFECTIONS AMONG ADULTS (2013)
Figure 12 CRIMINAL CASES ACROSS KEY REGIONS: RAPE AND HOMICIDE (2003-2014)
Figure 13 NUMBER OF NEW PRODUCT LAUNCHES: qPCR AND dPCR VS. COMPETITIVE MODALITIES, 2012–2015
Figure 14 dPCR IS EXPECTED TO BE THE FASTEST-GROWING PCR TECHOLOGY TILL 2021
Figure 15 TOP-DOWN APPROACH
Figure 16 BOTTOM-UP APPROACH
Figure 17 DATA TRIANGULATION
Figure 18 ASSUMPTIONS OF THE RESEARCH STUDY
Figure 19 GLOBAL qPCR AND dPCR MARKET, BY TECHNOLOGY, 2016 VS. 2021
Figure 20 GLOBAL qPCR AND dPCR PRODUCT AND SERVICES MARKET, 2016 VS. 2021
Figure 21 GLOBAL qPCR AND dPCR APPLICATIONS MARKET, 2016 VS. 2021
Figure 22 qPCR AND dPCR MARKET SHARE, BY REGION, 2016
Figure 23 MARKET GROWTH OPPORTUNITIES IN THE qPCR AND dPCR INDUSTRY
Figure 24 NORTH AMERICA EXPECTED TO DOMINATE qPCR AND dPCR MARKETS DURING THE STUDY PERIOD
Figure 25 REAGENTS AND CONSUMABLES TO DOMINATE THE qPCR AND dPCR PRODUCTS AND SERVICES MARKETS IN 2016
Figure 26 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF qPCR AND dPCR APPLICATIONS MARKETS IN 2016
Figure 27 NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF qPCR/dPCR APPLICATIONS MARKET IN 2016
Figure 28 HOSPITALS AND DIAGNOSTIC CENTERS TO DOMINATE THE qPCR END-USERS MARKET TILL 2021
Figure 29 KEY EVOLUTIONARY MILESTONES IN THE FIELD OF qPCR AND dPCR
Figure 30 RISING GERIATRIC POPULATION TO DRIVE THE MARKET DEMAND FOR dPCR AND qPCR PRODUCTS
Figure 31 HIV PREVALENCE, BY REGION, 2013
Figure 32 GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES (2015 VS. 2030)
Figure 33 TRADITIONAL PCR VS. qPCR: A COMPARATIVE STUDY
Figure 34 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE—DEVELOPED VS. DEVELOPING COUNTRIES (2010–2013)
Figure 35 VALUE CHAIN ANALYSIS (2006-2013): MAJOR VALUE IS ADDED TO OVERALL PRODUCT PRICE DURING MANUFACTURING PHASE
Figure 36 BUNDLED SALES STRATEGY ADOPTED BY KEY PRODUCT MANUFACTURERS IS LIMITING THREAT FROM NEW ENTRANTS
Figure 37 GROWING NUMBER OF NEW ENTRANTS IS STRENGTHENING THE MARKET COMPETITION
Figure 38 dPCR TECHNOLOGY IS PROJECTED TO BE THE FASTEST-GROWING TECHNOLOGY SEGMENT TILL 2021
Figure 39 qPCR REAGENTS & CONSUMABLES SEGMENT IS EXPECTED TO DOMINATE THE qPCR PRODUCTS & SERVICES MARKET DURING 2016-2021
Figure 40 dPCR INSTRUMENTS EXPECTED TO DOMINATE THE DPCR PRODUCTS & SERVICES MARKET DURING 2016-2021
Figure 41 CLINICAL APPLICATIONS TO DOMINATE GLOBAL qPCR MARKET DURING 2016-2021
Figure 42 CLINICAL APPLICATIONS TO DOMINATE GLOBAL dPCR MARKET DURING 2016-2021
Figure 43 HOSPITALS AND DIAGNOSTIC CENTERS TO DOMINATE THE qPCR END USER MARKET DURING 2016-2021
Figure 44 RESEARCH LABS AND ACADEMIC INSTITUTES TO DOMINATE THE dPCR END-USER MARKET DURING 2016-2021
Figure 45 NORTH AMERICAN qPCR AND dPCR MARKET SNAPSHOT (2016–2021)
Figure 46 EUROPEAN qPCR AND dPCR MARKET SNAPSHOT (2016–2021)
Figure 47 ASIA-PACIFIC qPCR AND dPCR MARKET SNAPSHOT (2016–2021)
Figure 48 ROW qPCR AND dPCR MARKET SNAPSHOT (2016–2021)
Figure 49 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS AS THEIR KEY GROWTH STRATEGY DURING 2012–2015
Figure 50 GLOBAL qPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
Figure 51 GLOBAL dPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
Figure 52 INCREASE IN NUMBER OF INNOVATIVE qPCR AND dPCR PRODUCTS IS STIMULATING MARKET GROWTH
Figure 53 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS (2015)
Figure 54 PRODUCT DEVELOPMENT AND COMMERCIALIZATION, THE KEY GROWTH STRATEGY ADOPTED BY QPCR AND DPCR MARKET PLAYERS
Figure 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
Figure 56 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
Figure 57 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
Figure 58 QIAGEN N.V.: COMPANY SNAPSHOT
Figure 59 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
Figure 60 TAKARA BIO, INC.: COMPANY SNAPSHOT
Figure 61 BIOM?RIEUX S.A.: COMPANY SNAPSHOT
Figure 62 AFFYMETRIX, INC.: COMPANY SNAPSHOT
Figure 63 FLUIDIGM CORPORATION: COMPANY SNAPSHOT
Figure 1 RESEARCH DESIGN
Figure 2 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2000-2013
Figure 3 HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS: 2000-2013
Figure 4 HEALTHCARE SPENDING MATRIX: KEY MARKETS (2013)
Figure 5 INCREASE IN AGING POPULATION, BY COUNTRY (2011-2030)
Figure 6 PERCENTAGE INCREASE IN AGING POPULATION, BY REGION (1980–2010 VS. 2010–2040)
Figure 7 GLOBAL BURDEN OF CANCER, BY REGION (2005–2030)
Figure 8 NUMBER OF NEW CANCER CASES, BY COUNTRY (2012 VS. 2020)
Figure 9 INCREASING INCIDENCE OF VARIOUS CANCERS, 2008–2020
Figure 10 ANNUAL BIRTH RATE IN DEVELOPED AND DEVELOPING NATIONS (2014)
Figure 11 GLOBAL PREVALENCE OF HIV INFECTIONS AMONG ADULTS (2013)
Figure 12 CRIMINAL CASES ACROSS KEY REGIONS: RAPE AND HOMICIDE (2003-2014)
Figure 13 NUMBER OF NEW PRODUCT LAUNCHES: qPCR AND dPCR VS. COMPETITIVE MODALITIES, 2012–2015
Figure 14 dPCR IS EXPECTED TO BE THE FASTEST-GROWING PCR TECHOLOGY TILL 2021
Figure 15 TOP-DOWN APPROACH
Figure 16 BOTTOM-UP APPROACH
Figure 17 DATA TRIANGULATION
Figure 18 ASSUMPTIONS OF THE RESEARCH STUDY
Figure 19 GLOBAL qPCR AND dPCR MARKET, BY TECHNOLOGY, 2016 VS. 2021
Figure 20 GLOBAL qPCR AND dPCR PRODUCT AND SERVICES MARKET, 2016 VS. 2021
Figure 21 GLOBAL qPCR AND dPCR APPLICATIONS MARKET, 2016 VS. 2021
Figure 22 qPCR AND dPCR MARKET SHARE, BY REGION, 2016
Figure 23 MARKET GROWTH OPPORTUNITIES IN THE qPCR AND dPCR INDUSTRY
Figure 24 NORTH AMERICA EXPECTED TO DOMINATE qPCR AND dPCR MARKETS DURING THE STUDY PERIOD
Figure 25 REAGENTS AND CONSUMABLES TO DOMINATE THE qPCR AND dPCR PRODUCTS AND SERVICES MARKETS IN 2016
Figure 26 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF qPCR AND dPCR APPLICATIONS MARKETS IN 2016
Figure 27 NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF qPCR/dPCR APPLICATIONS MARKET IN 2016
Figure 28 HOSPITALS AND DIAGNOSTIC CENTERS TO DOMINATE THE qPCR END-USERS MARKET TILL 2021
Figure 29 KEY EVOLUTIONARY MILESTONES IN THE FIELD OF qPCR AND dPCR
Figure 30 RISING GERIATRIC POPULATION TO DRIVE THE MARKET DEMAND FOR dPCR AND qPCR PRODUCTS
Figure 31 HIV PREVALENCE, BY REGION, 2013
Figure 32 GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES (2015 VS. 2030)
Figure 33 TRADITIONAL PCR VS. qPCR: A COMPARATIVE STUDY
Figure 34 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE—DEVELOPED VS. DEVELOPING COUNTRIES (2010–2013)
Figure 35 VALUE CHAIN ANALYSIS (2006-2013): MAJOR VALUE IS ADDED TO OVERALL PRODUCT PRICE DURING MANUFACTURING PHASE
Figure 36 BUNDLED SALES STRATEGY ADOPTED BY KEY PRODUCT MANUFACTURERS IS LIMITING THREAT FROM NEW ENTRANTS
Figure 37 GROWING NUMBER OF NEW ENTRANTS IS STRENGTHENING THE MARKET COMPETITION
Figure 38 dPCR TECHNOLOGY IS PROJECTED TO BE THE FASTEST-GROWING TECHNOLOGY SEGMENT TILL 2021
Figure 39 qPCR REAGENTS & CONSUMABLES SEGMENT IS EXPECTED TO DOMINATE THE qPCR PRODUCTS & SERVICES MARKET DURING 2016-2021
Figure 40 dPCR INSTRUMENTS EXPECTED TO DOMINATE THE DPCR PRODUCTS & SERVICES MARKET DURING 2016-2021
Figure 41 CLINICAL APPLICATIONS TO DOMINATE GLOBAL qPCR MARKET DURING 2016-2021
Figure 42 CLINICAL APPLICATIONS TO DOMINATE GLOBAL dPCR MARKET DURING 2016-2021
Figure 43 HOSPITALS AND DIAGNOSTIC CENTERS TO DOMINATE THE qPCR END USER MARKET DURING 2016-2021
Figure 44 RESEARCH LABS AND ACADEMIC INSTITUTES TO DOMINATE THE dPCR END-USER MARKET DURING 2016-2021
Figure 45 NORTH AMERICAN qPCR AND dPCR MARKET SNAPSHOT (2016–2021)
Figure 46 EUROPEAN qPCR AND dPCR MARKET SNAPSHOT (2016–2021)
Figure 47 ASIA-PACIFIC qPCR AND dPCR MARKET SNAPSHOT (2016–2021)
Figure 48 ROW qPCR AND dPCR MARKET SNAPSHOT (2016–2021)
Figure 49 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS AS THEIR KEY GROWTH STRATEGY DURING 2012–2015
Figure 50 GLOBAL qPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
Figure 51 GLOBAL dPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
Figure 52 INCREASE IN NUMBER OF INNOVATIVE qPCR AND dPCR PRODUCTS IS STIMULATING MARKET GROWTH
Figure 53 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS (2015)
Figure 54 PRODUCT DEVELOPMENT AND COMMERCIALIZATION, THE KEY GROWTH STRATEGY ADOPTED BY QPCR AND DPCR MARKET PLAYERS
Figure 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
Figure 56 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
Figure 57 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
Figure 58 QIAGEN N.V.: COMPANY SNAPSHOT
Figure 59 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
Figure 60 TAKARA BIO, INC.: COMPANY SNAPSHOT
Figure 61 BIOM?RIEUX S.A.: COMPANY SNAPSHOT
Figure 62 AFFYMETRIX, INC.: COMPANY SNAPSHOT
Figure 63 FLUIDIGM CORPORATION: COMPANY SNAPSHOT
